688526 科前生物
已收盘 05-14 15:00:01
资讯
新帖
简况
股市必读：科前生物一季报 - 第一季度单季净利润同比下降26.79%
证券之星 · 05-06
股市必读：科前生物一季报 - 第一季度单季净利润同比下降26.79%
东兴证券：给予科前生物买入评级
证券之星 · 05-05
东兴证券：给予科前生物买入评级
每周股票复盘：科前生物（688526）一季度净利降26.79%
证券之星 · 05-02
每周股票复盘：科前生物（688526）一季度净利降26.79%
科前生物（688526）2026年一季报简析：净利润同比下降26.79%，公司应收账款体量较大
证券之星 · 05-01
科前生物（688526）2026年一季报简析：净利润同比下降26.79%，公司应收账款体量较大
科前生物(688526)3月31日股东户数1.07万户，较上期增加0.05%
证券之星 · 04-30
科前生物(688526)3月31日股东户数1.07万户，较上期增加0.05%
图解科前生物一季报：第一季度单季净利润同比下降26.79%
证券之星 · 04-30
图解科前生物一季报：第一季度单季净利润同比下降26.79%
每周股票复盘：科前生物（688526）2025年净利增9.51%
证券之星 · 04-19
每周股票复盘：科前生物（688526）2025年净利增9.51%
科前生物（688526）披露2025年年度股东会会议材料，4月16日股价上涨0.26%
证券之星 · 04-16
科前生物（688526）披露2025年年度股东会会议材料，4月16日股价上涨0.26%
科前生物（688526）2025年年报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 04-09
科前生物（688526）2025年年报简析：营收净利润同比双双增长，盈利能力上升
科前生物（688526）披露2025年年度报告，4月7日股价上涨2.53%
证券之星 · 04-07
科前生物（688526）披露2025年年度报告，4月7日股价上涨2.53%
科前生物(688526.SH)发布2025年度业绩，归母净利润4.19亿元，同比增长9.51%
智通财经 · 04-07
科前生物(688526.SH)发布2025年度业绩，归母净利润4.19亿元，同比增长9.51%
科前生物（688526）披露拟与华中农大签订合作研发协议暨关联交易公告，3月24日股价上涨2.11%
证券之星 · 03-24
科前生物（688526）披露拟与华中农大签订合作研发协议暨关联交易公告，3月24日股价上涨2.11%
科前生物(688526.SH)拟与华中农大签订合作研发协议
智通财经 · 03-24
科前生物(688526.SH)拟与华中农大签订合作研发协议
3月23日科前生物跌6.87%，鹏扬中国优质成长混合A基金重仓该股
证券之星 · 03-23
3月23日科前生物跌6.87%，鹏扬中国优质成长混合A基金重仓该股
科前生物新注册《DeepiMotif 在线预测工具（web端）1.0》项目的软件著作权
证券之星 · 03-15
科前生物新注册《DeepiMotif 在线预测工具（web端）1.0》项目的软件著作权
股市必读：科前生物发布2025年度业绩快报，盈利4.156亿元
证券之星 · 03-02
股市必读：科前生物发布2025年度业绩快报，盈利4.156亿元
每周股票复盘：科前生物（688526）2025年净利增8.7%
证券之星 · 03-01
每周股票复盘：科前生物（688526）2025年净利增8.7%
科前生物（688526）披露2025年度业绩快报，2月27日股价上涨0.06%
证券之星 · 02-27
科前生物（688526）披露2025年度业绩快报，2月27日股价上涨0.06%
科前生物：公司于2023年底作为投资人参与了四川德康农牧食品集团股份有限公司港交所IPO
证券日报 · 02-11
科前生物：公司于2023年底作为投资人参与了四川德康农牧食品集团股份有限公司港交所IPO
科前生物(688526.SH)获批一款新兽药注册证书
智通财经 · 02-09
科前生物(688526.SH)获批一款新兽药注册证书
加载更多
公司概况
公司名称：
武汉科前生物股份有限公司
所属行业：
医药制造业
上市日期：
2020-09-22
主营业务：
武汉科前生物股份有限公司的主营业务是专注于兽用生物制品研发、生产、销售及动物防疫技术服务。公司的主要产品是兽用生物制品。公司共获得2项国家科学技术进步奖二等奖、6项湖北省科技进步奖一等奖、1项湖北省科技进步二等奖，5项国家重点新产品证书。
发行价格：
11.69
{"stockData":{"symbol":"688526","market":"SH","secType":"STK","nameCN":"科前生物","latestPrice":14.55,"timestamp":1778742001000,"preClose":14.77,"halted":0,"volume":1299456,"delay":0,"changeRate":-0.0149,"floatShares":466000000,"shares":466000000,"eps":0.8361,"marketStatus":"已收盘","change":-0.22,"latestTime":"05-14 15:00:01","open":14.79,"high":14.81,"low":14.53,"amount":19019200,"amplitude":0.019,"askPrice":14.56,"askSize":33,"bidPrice":14.55,"bidSize":2,"shortable":0,"etf":0,"ttmEps":0.8361,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778808600000},"marketStatusCode":5,"adr":0,"adjPreClose":14.77,"symbolType":"stock_kcb","openAndCloseTimeList":[[1778722200000,1778729400000],[1778734800000,1778742000000]],"highLimit":16.25,"lowLimit":13.29,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":466128056,"isCdr":false,"pbRate":1.57,"roa":"--","peRate":17.402225,"roe":"1.85%","epsLYR":0.9,"committee":0.770795,"marketValue":6782000000,"turnoverRate":0.0028,"status":1,"afterMarket":{"amount":0,"volume":0,"close":14.55,"buyVolume":0,"sellVolume":0,"time":1778744037558,"indexStatus":"已收盘 05-14 15:30:00","preClose":14.77},"floatMarketCap":6782000000},"requestUrl":"/m/hq/s/688526/","defaultTab":"news","newsList":[{"id":"2633921821","title":"股市必读：科前生物一季报 - 第一季度单季净利润同比下降26.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633921821","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633921821?lang=zh_cn&edition=full","pubTime":"2026-05-06 04:20","pubTimestamp":1778012418,"startTime":"0","endTime":"0","summary":"来自业绩披露要点：科前生物2026年一季度归母净利润7923.62万元，同比下降26.79%。公司公告汇总武汉科前生物股份有限公司2025年年度暨2026年第一季度业绩暨现金分红说明会公告武汉科前生物股份有限公司将于2026年5月13日13:00-14:00通过上证路演中心网络互动方式召开2025年年度暨2026年第一季度业绩暨现金分红说明会。投资者可于2026年5月6日至5月12日16:00前通过上证路演中心网站或公司邮箱提交问题。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600003490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633899488","title":"东兴证券：给予科前生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2633899488","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633899488?lang=zh_cn&edition=full","pubTime":"2026-05-05 14:00","pubTimestamp":1777960844,"startTime":"0","endTime":"0","summary":"东兴证券股份有限公司程诗月近期对科前生物进行研究并发布了研究报告《主业经营稳健，坚定研发投入》，给予科前生物买入评级。此外，公司计提了信用减值损失和资产减值损失合计1362.74万。最新盈利预测明细如下：该股最近90天内共有7家机构给出评级，买入评级7家；过去90天内机构目标均价为18.0。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050500003923.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601198","688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632406996","title":"每周股票复盘：科前生物（688526）一季度净利降26.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632406996","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632406996?lang=zh_cn&edition=full","pubTime":"2026-05-02 04:48","pubTimestamp":1777668491,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，科前生物报收于14.41元，较上周的14.77元下跌2.44%。业绩披露要点：2026年一季报归母净利润7923.62万元，同比下降26.79%。公司公告汇总：科前生物将于2026年5月13日召开年度及一季度业绩说明会。股本股东变化截至2026年3月31日，科前生物股东户数为1.07万户，较2025年12月31日增加5.0户，增幅0.05%。科前生物2025年年度股东会出席会议股东及代理人共118人，代表有表决权股份319,044,688股，占公司总股本的68.4457%，所有议案均获通过。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200002846.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632660261","title":"科前生物（688526）2026年一季报简析：净利润同比下降26.79%，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2632660261","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632660261?lang=zh_cn&edition=full","pubTime":"2026-05-01 06:50","pubTimestamp":1777589452,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期科前生物发布2026年一季报。截至本报告期末，公司营业总收入2.28亿元，同比下降7.2%，归母净利润7923.62万元，同比下降26.79%。本报告期科前生物公司应收账款体量较大，当期应收账款占最新年报归母净利润比达76.33%。然而去年的净利率为43.9%，算上全部成本后，公司产品或服务的附加值极高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100007363.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631684675","title":"科前生物(688526)3月31日股东户数1.07万户，较上期增加0.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631684675","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631684675?lang=zh_cn&edition=full","pubTime":"2026-04-30 17:35","pubTimestamp":1777541713,"startTime":"0","endTime":"0","summary":"户均持股数量由上期的4.38万股减少至4.37万股，户均持股市值为63.5万元。在动物保健行业个股中，科前生物股东户数低于行业平均水平，截至3月31日，动物保健行业平均股东户数为2.23万户。从股价来看，2025年12月31日至2026年3月31日，科前生物区间跌幅为4.85%，在此期间股东户数增加5.0户，增幅为0.05%。根据统计，科前生物2025年12月31日至2026年3月31日，主力资金净流出7142.16万元，游资资金净流入7535.49万元，散户资金净流出393.33万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000056566.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631354045","title":"图解科前生物一季报：第一季度单季净利润同比下降26.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631354045","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631354045?lang=zh_cn&edition=full","pubTime":"2026-04-30 02:39","pubTimestamp":1777487958,"startTime":"0","endTime":"0","summary":"证券之星消息，科前生物2026年一季报显示，一季度公司主营收入2.28亿元，同比下降7.2%；归母净利润7923.62万元，同比下降26.79%；扣非净利润6945.19万元，同比下降24.19%；负债率10.62%，投资收益214.55万元，财务费用-1071.75万元，毛利率64.0%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000007728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628786759","title":"每周股票复盘：科前生物（688526）2025年净利增9.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628786759","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628786759?lang=zh_cn&edition=full","pubTime":"2026-04-19 03:05","pubTimestamp":1776539112,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，科前生物报收于15.1元，较上周的15.05元上涨0.33%。本周，科前生物4月16日盘中最高价报15.25元。公司2025年实现营业收入94,974.20万元，同比增长0.83%；归属于母公司所有者的净利润41,872.32万元，同比增长9.51%。拟每10股派发现金红利6.4元（含税），现金分红及回购合计占净利润71.50%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900001041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627296147","title":"科前生物（688526）披露2025年年度股东会会议材料，4月16日股价上涨0.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627296147","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627296147?lang=zh_cn&edition=full","pubTime":"2026-04-16 17:43","pubTimestamp":1776332626,"startTime":"0","endTime":"0","summary":"截至2026年4月16日收盘，科前生物报收于15.21元，较前一交易日上涨0.26%，最新总市值为70.9亿元。该股当日开盘15.2元，最高15.25元，最低15.06元，成交额达3054.69万元，换手率为0.43%。武汉科前生物股份有限公司于2026年4月16日披露《2025年年度股东会会议材料》。公司2025年实现营业收入94,974.20万元，同比增长0.83%；归属于母公司所有者的净利润41,872.32万元，同比增长9.51%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600032251.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626384978","title":"科前生物（688526）2025年年报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2626384978","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626384978?lang=zh_cn&edition=full","pubTime":"2026-04-09 06:03","pubTimestamp":1775685804,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期科前生物发布2025年年报。截至本报告期末，公司营业总收入9.5亿元，同比上升0.83%，归母净利润4.19亿元，同比上升9.51%。本报告期科前生物盈利能力上升，毛利率同比增幅5.05%，净利率同比增幅8.39%。该数据低于大多数分析师的预期，此前分析师普遍预期2025年净利润为盈利4.51亿元左右。筹资活动产生的现金流量净额变动幅度为63.38%,原因:偿还债务支付的现金减少。应交税费变动幅度为45.82%,原因:应交企业所得税增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900003204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625195130","title":"科前生物（688526）披露2025年年度报告，4月7日股价上涨2.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625195130","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625195130?lang=zh_cn&edition=full","pubTime":"2026-04-07 22:40","pubTimestamp":1775572822,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘，科前生物报收于15.01元，较前一交易日上涨2.53%，最新总市值为69.97亿元。近日，武汉科前生物股份有限公司披露《2025年年度报告》。经营活动产生的现金流量净额为468,541,833.22元，同比增长19.32%。总资产为4,789,205,283.26元，同比增长6.53%；归属于上市公司股东的净资产为4,238,780,870.21元，同比增长7.56%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700033696.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625895342","title":"科前生物(688526.SH)发布2025年度业绩，归母净利润4.19亿元，同比增长9.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625895342","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625895342?lang=zh_cn&edition=full","pubTime":"2026-04-07 21:00","pubTimestamp":1775566808,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科前生物(688526.SH)披露2025年年度报告，报告期公司实现营收9.5亿元，同比增长0.83%;归属于上市公司股东的净利润4.19亿元，同比增长9.51%;扣非净利润3.52亿元，同比增长12.74%;基本每股收益0.90元。公司拟向全体股东每10股派发现金红利6.4元(含税)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425588.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621954450","title":"科前生物（688526）披露拟与华中农大签订合作研发协议暨关联交易公告，3月24日股价上涨2.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621954450","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621954450?lang=zh_cn&edition=full","pubTime":"2026-03-24 22:43","pubTimestamp":1774363400,"startTime":"0","endTime":"0","summary":"截至2026年3月24日收盘，科前生物报收于14.53元，较前一交易日上涨2.11%，最新总市值为67.73亿元。近日，武汉科前生物股份有限公司发布《关于拟与华中农大签订合作研发协议暨关联交易的自愿性披露公告》。公告显示，公司拟与华中农业大学签订联合开发协议，合作研发“猫四联灭活疫苗”与“猫支原体灭活疫苗”项目，公司需向华中农大支付100万元研发费用。本次交易构成关联交易，已获公司董事会审议通过，无需提交股东会审议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400040322.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621502320","title":"科前生物(688526.SH)拟与华中农大签订合作研发协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2621502320","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621502320?lang=zh_cn&edition=full","pubTime":"2026-03-24 17:14","pubTimestamp":1774343656,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科前生物 发布公告，为增强公司市场竞争力，加快公司在生物制品行业的发展，从而更好提升公司品牌影响力和核心竞争力，根据《公司章程》、《合作研发管理制度》等规定，经与华中农大竞争性谈判，取得了“猫四联灭活疫苗与猫支原体灭活疫苗”项目的合作研发，现拟就上述项目与华中农大签订联合合作研发协议，公司就上述研发项目需向华中农大支付100万元人民币。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418057.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621776613","title":"3月23日科前生物跌6.87%，鹏扬中国优质成长混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2621776613","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621776613?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:41","pubTimestamp":1774255274,"startTime":"0","endTime":"0","summary":"证券之星消息，3月23日科前生物跌6.87%创60日新低，收盘报14.23元，换手率1.18%，成交量5.51万手，成交额8007.01万元。重仓科前生物的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为鹏扬基金的鹏扬中国优质成长混合A。鹏扬中国优质成长混合A目前规模为3.72亿元，最新净值0.9047，较上一交易日下跌0.46%，近一年上涨19.92%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300025406.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619012033","title":"科前生物新注册《DeepiMotif 在线预测工具（web端）1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2619012033","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619012033?lang=zh_cn&edition=full","pubTime":"2026-03-15 01:49","pubTimestamp":1773510552,"startTime":"0","endTime":"0","summary":"证券之星消息，近日科前生物（688526）新注册了《DeepiMotif 在线预测工具（web端）1.0》项目的软件著作权。今年以来科前生物新注册软件著作权1个。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了4549.75万元，同比增12.73%。通过天眼查大数据分析，武汉科前生物股份有限公司共对外投资了4家企业，参与招投标项目536次；财产线索方面有商标信息65条，专利信息196条；此外企业还拥有行政许可507个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031500000359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616761718","title":"股市必读：科前生物发布2025年度业绩快报，盈利4.156亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616761718","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616761718?lang=zh_cn&edition=full","pubTime":"2026-03-02 03:10","pubTimestamp":1772392223,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，科前生物报收于16.76元，上涨0.06%，换手率0.4%，成交量1.89万手，成交额3159.33万元。业绩披露要点科前生物近日即将发布2025年年报，根据2月27日发布的业绩快报，归属净利润盈利4.156亿元，同比增长8.7%。公司公告汇总武汉科前生物股份有限公司发布2025年度业绩快报，营业总收入950,292,353.15元，同比增长0.89%；归属于上市公司股东的净利润415,596,193.12元，同比增长8.70%。总资产4,790,335,880.58元，较年初增长6.55%；归属于上市公司股东的所有者权益4,242,116,569.09元，增长7.64%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200001438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616845618","title":"每周股票复盘：科前生物（688526）2025年净利增8.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616845618","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616845618?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:45","pubTimestamp":1772304313,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，科前生物报收于16.76元，较上周的16.23元上涨3.27%。本周，科前生物2月26日盘中最高价报16.84元。本周关注点来自业绩披露要点：科前生物2025年归属净利润同比增长8.7%。公司公告汇总武汉科前生物股份有限公司发布2025年度业绩快报，营业总收入950,292,353.15元，同比增长0.89%；归属于上市公司股东的净利润415,596,193.12元，同比增长8.70%。总资产4,790,335,880.58元，较年初增长6.55%；归属于上市公司股东的所有者权益4,242,116,569.09元，增长7.64%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614857081","title":"科前生物（688526）披露2025年度业绩快报，2月27日股价上涨0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614857081","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614857081?lang=zh_cn&edition=full","pubTime":"2026-02-27 23:16","pubTimestamp":1772205378,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，科前生物报收于16.76元，较前一交易日上涨0.06%，最新总市值为78.12亿元。该股当日开盘16.82元，最高16.83元，最低16.67元，成交额达3159.33万元，换手率为0.4%。近日，武汉科前生物股份有限公司披露《2025年度业绩快报公告》。公告显示，公司2025年营业总收入950,292,353.15元，同比增长0.89%；归属于上市公司股东的净利润415,596,193.12元，同比增长8.70%。总资产4,790,335,880.58元，较年初增长6.55%；归属于上市公司股东的所有者权益4,242,116,569.09元，增长7.64%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700043186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610834958","title":"科前生物：公司于2023年底作为投资人参与了四川德康农牧食品集团股份有限公司港交所IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2610834958","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610834958?lang=zh_cn&edition=full","pubTime":"2026-02-11 21:07","pubTimestamp":1770815220,"startTime":"0","endTime":"0","summary":"证券日报网讯 2月11日，科前生物在互动平台回答投资者提问时表示，公司于2023年底作为投资人参与了四川德康农牧食品集团股份有限公司港交所IPO，公司投资德康农牧系为了加强与客户之间的沟通合作，并非为了近期出售或回购，不是为了投资获益等目的，因此将相关投资指定为以公允价值计量且其变动计入其他综合收益的金融资产，在其他权益工具投资中列报。具体信息请关注公司定期报告中财务报表章节之“七、合并财务报表项目注释”之“18、其他权益工具投资”。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-02-11/doc-inhmnhrc4536370.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-02-11/doc-inhmnhrc4536370.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HEXmain","BK0239","02419","688526","159151","BK1237"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610568216","title":"科前生物(688526.SH)获批一款新兽药注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2610568216","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610568216?lang=zh_cn&edition=full","pubTime":"2026-02-09 15:40","pubTimestamp":1770622813,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科前生物(688526.SH)发布公告，根据《兽药管理条例》和《兽药注册办法》规定，经中华人民共和国农业农村部审查，批准公司申报的猪圆环病毒2型重组杆状病毒灭活疫苗(CH17株，悬浮培养)为新兽药，并核发《新兽药注册证书》。该产品的成功获批，将进一步丰富公司的产品种类，推动公司产品及业务向多元化方向发展，有利于进一步提升公司的市场竞争力，对公司经营发展具有一定的积极作用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403110.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"科前生物(688526.SH)获批一款新兽药注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778777054700,"stockEarnings":[{"period":"1week","weight":-0.0109},{"period":"1month","weight":-0.0345},{"period":"3month","weight":-0.1035},{"period":"6month","weight":-0.1224},{"period":"1year","weight":-0.1089},{"period":"ytd","weight":-0.0465}],"compareEarnings":[{"period":"1week","weight":-0.0005},{"period":"1month","weight":0.0376},{"period":"3month","weight":0.0235},{"period":"6month","weight":0.047},{"period":"1year","weight":0.2274},{"period":"ytd","weight":0.0527}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"武汉科前生物股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"10659人(较上一季度增加0.05%)","perCapita":"43730股","listingDate":"2020-09-22","address":"湖北省武汉市江夏区东湖新技术开发区高新二路419号","registeredCapital":"46612万元","survey":" 武汉科前生物股份有限公司的主营业务是专注于兽用生物制品研发、生产、销售及动物防疫技术服务。公司的主要产品是兽用生物制品。公司共获得2项国家科学技术进步奖二等奖、6项湖北省科技进步奖一等奖、1项湖北省科技进步二等奖，5项国家重点新产品证书。","listedPrice":11.69},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科前生物(688526)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科前生物(688526)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科前生物,688526,科前生物股票,科前生物股票老虎,科前生物股票老虎国际,科前生物行情,科前生物股票行情,科前生物股价,科前生物股市,科前生物股票价格,科前生物股票交易,科前生物股票购买,科前生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科前生物(688526)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科前生物(688526)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}